GPT Healthcare IPO Review: Should You Apply or Not?

As the GPT Healthcare IPO garners attention in the market, investors are wondering whether they should apply for this public issue or not. This article will provide a comprehensive review of the IPO, including the Grey Market Premium (GMP), subscription status, and expert recommendations.

GPT Healthcare IPO Subscription Status:

In the first two days of bidding, the GPT Healthcare IPO has been subscribed 0.85 times. By the third day, the subscription had increased to 1.18 times, with the retail portion oversubscribed at 1.57 times. The NII segment was subscribed at 1.60 times, while the QIB portion lagged behind at 0.19 times.

GPT Healthcare IPO GMP:

The Grey Market Premium for GPT Healthcare IPO has seen an improvement, currently standing at ₹9. This indicates a positive sentiment towards the IPO in the grey market, with a noticeable increase from the initial zero premium on the first day of bidding.

Expert Recommendations:

Leading brokerage firms like Reliance Securities, Anand Rathi, and Nirmal Bang have given a “Subscribe” rating to GPT Healthcare Ltd. They highlight the company’s strong positioning in the healthcare market, diversified specialty mix, and ability to attract quality medical professionals. Anand Rathi believes the company is fairly priced and recommends a “Subscribe – Long Term” rating to the IPO.

Should You Apply for GPT Healthcare IPO?

Considering the positive expert recommendations and the improved sentiment in the grey market, investors may find the GPT Healthcare IPO a promising investment opportunity. However, it is essential to conduct thorough research and consult with financial experts before making any investment decisions.


  1. What is the current subscription status of GPT Healthcare IPO?
    • The IPO has been subscribed 1.18 times by the third day of bidding.
  2. What is the Grey Market Premium for GPT Healthcare IPO?
    • The GMP is currently at ₹9.
  3. Which brokerage firms have recommended a “Subscribe” rating for GPT Healthcare IPO?
    • Reliance Securities, Anand Rathi, and Nirmal Bang have given the recommendation.
  4. What are some key positives highlighted by brokerage firms about GPT Healthcare Ltd?
    • Strong positioning in underserved healthcare markets, diversified specialty mix, and ability to retain quality medical professionals.
  5. What is the expected growth rate of the healthcare delivery market in India?
    • The market is expected to grow at a CAGR of 9%-11% between Fiscal Years 2024 and 2028.

In conclusion, the GPT Healthcare IPO shows promise with positive expert recommendations and improving subscription status. Investors willing to undertake the necessary due diligence may consider applying for this public issue.

Leave a Comment